CS Paper Radar

Does DCGAN-Based Synthetic Augmentation Improve Brain Tumor MRI Classification? An Empirical Study

Irhum Jawad Khan, Talha bin Aslam

eess.IV cs.CV ·submitted 2026-09-20 11:42 UTC · v1

Abstract

Generative adversarial networks (GANs) are increasingly used to augment medical imaging datasets, but synthetic images do not necessarily provide downstream classification benefits. This study investigates whether class-specific Deep Convolutional Generative Adversarial Network (DCGAN) augmentation improves brain tumor classification when the classifier and evaluation set are held constant. Experiments were conducted on 7,200 brain magnetic resonance imaging (MRI) scans across four classes: glioma, meningioma, pituitary tumor, and no tumor. For each class, 1,400 real images were used for training and 400 were reserved for testing. A baseline Swin Transformer classifier was trained using only the real training images and compared with a second model trained using the same real images augmented with 500 DCGAN-generated images per class. Both conditions were evaluated on the identical held-out test set. The two models achieved the same overall accuracy of 96%, while macro F1 remained effectively unchanged and ROC-AUC decreased slightly from 0.987 to 0.982 after augmentation. Class-level analysis showed small redistributions in errors rather than a consistent performance gain. FID values between real and synthetic images ranged from 209.15 to 314.27, indicating substantial distributional differences under the adopted evaluation setup. These results suggest that synthetic augmentation should not be assumed to improve medical image classification and should instead be evaluated for both distributional fidelity and downstream task utility.

Closest papers

Nearest neighbours by meaning across the whole index.

A Comparative Study of GAN-Based Deep Learning Models for Pneumonia Detection in Chest X-Rays

cs.CV ·2026-09-05 ·Roshan Paudel, Aashish Ghimire, Pramod Acharya
similarity 0.72
Abstract

This study evaluates pneumonia classification in chest X-rays using VGG19, MobileNetV2, ResNet50, and a custom CNN, and explores Generative Adversarial Network (GAN)-based synthetic data augmentation. MobileNetV2 achieved the highest reported accuracy of 88% with balanced class-wise performance. The custom CNN achieved pneumonia recall of 92.67% and precision of 79.43%, highlighting a precision-recall trade-off. Accuracy, F1-score, precision, recall, confusion matrices, and training curves were used to assess performance. Synthetic pneumonia images were combined with real images to investigate whether augmentation could improve classification performance. In the reported VGG19 comparison, augmented-data training accuracy reached approximately 100%, while validation accuracy remained near 50%, below the real-data validation accuracy. This experiment therefore did not demonstrate a validation-performance benefit from GAN augmentation. The classifier comparison highlights differences in accuracy and pneumonia recall, while the augmentation experiment indicates the need for further evaluation of synthetic-image quality and training settings.

0.26

Benchmarking CNNs, Vision Transformers, and Foundation Models for Explainable Brain Tumor MRI Classification: Calibration, Decision Analysis, and External Validation

cs.CV ·2026-11-09 ·Akwasi Asare
similarity 0.69
Abstract · Under review at Scientific Report Journal, Springer

Deep learning models for brain tumor MRI classification are usually compared by accuracy alone, on public datasets whose independence is rarely checked. We benchmarked six architectures: two convolutional networks (EfficientNetV2-M and ConvNeXt-V2-Tiny), two vision transformers (Swin-V2-S and ViT-L/16), and two foundation models (DINOv2-L and MedSigLIP-448), for four-class classification of 7,216 public MRI images. We assessed accuracy, calibration, explainability, ensembles, and decision curves, with every fitted quantity estimated on validation data only. Pixel-verified duplicate screening showed that 36% of the test images had a near-duplicate in the training data. Test accuracy ranged from 94.5% to 95.6%, with no pairwise difference after Holm correction, and fell to 90.3% to 91.7% on the 773 test images free of duplicates and shared patients. Ensembles did not outperform the best single model. Attribution maps passed a model-randomization test but localized expert-annotated tumors poorly. On 1,675 external BDNeuro-MRI images that did not duplicate the training data, accuracy ranged from 77.6% (MedSigLIP-448) to 95.0% (ViT-L/16), and 12 of 15 pairwise differences were significant. Internal accuracy on this public collection therefore did not distinguish the architectures, whereas the duplicate-filtered external test did.

0.15

Generative AI-Based Data Augmentation for Oral Lesion Classification: The PhotoMOCI Dataset and Benchmark

cs.CV cs.AI ·2026-09-28 ·Marco Parola, Mario G. C. A. Cimino, Sabrina Senatore
publishedbenchmark similarity 0.69
Abstract

Early detection of oral cancer via photographic imaging presents a promising avenue for large-scale oral cavity screening. However, the development of robust deep learning models is frequently hampered by the scarcity of high-quality, annotated datasets. To address this limitation, a novel and well-curated resource, the Photographic Multi-purpose Oral Cancer Imaging (PhotoMOCI) dataset, is introduced for developing models across multiple diagnostic tasks in oral oncology. Then, a comprehensive benchmark study was conducted to investigate how various data augmentation strategies influence the performance of image classifiers. Our analysis spans different generative AI frameworks, evaluating the efficacy of traditional methods against advanced generative approaches, including Generative Adversarial Networks (GANs) and Diffusion Models (DMs). Additionally, we propose the Synthetic Image Filter (SIF), a mechanism to select specific samples based on two auxiliary models: Synthetic Proxy Classifier to ensure samples are representative of the target class and Synthetic Image Detector to verify they appear realistic, thereby selecting only the high-utility images that contribute to improving downstream performance. Across the evaluated datasets and classifiers, the best SIF-filtered setup improves accuracy over traditional augmentation in all cases, with gains of +1.73% and +2.35% on PhotoMOCI and +2.38% and +2.08% on KOCD for ResNet50 and ViT, respectively. Our findings reveal that while the direct application of generative data augmentation may yield performance drops, the integration of SIF, considering (i) how synthetic data looks real and (ii) how it reflects the discriminative features of the belonging class, provides a simple yet effective mechanism to filter out synthetic samples that confuse the classifier during training.

0.18

How Robust Are CNNs and Vision Transformers for Alzheimer's MRI Classification Across Datasets?

cs.CV ·2026-10-24 ·Hafija Aktar, Molly Croes, Frank S. Menniti, Abdeltawab Hendawi
dataset similarity 0.69
Abstract · 12 pages, 9 tables, 3 figures. Submitted to Biomedical Signal Processing and Control

Accurate assessment of Alzheimer's disease stages from MRI is important for understanding disease progression and supporting the development of computer-aided analysis tools. Deep learning models have shown promising results for Alzheimer's disease classification from MRI. However, when evaluated on single datasets, it is difficult to determine whether the observed performance reflects consistent architectural behavior or dataset-specific effects. In this work, we present a multi-dataset benchmarking framework with standardized preprocessing and evaluation. We compare five architectures: ResNet-50, ReXNet-150, Swin Transformer, ViT-Base, and ViT-Large. The models are evaluated across three MRI datasets representing severe class imbalance, train-test distribution mismatch, and large-scale augmentation. The results show broadly consistent performance patterns across datasets, with ViT-Large achieving the best performance on all three datasets and reaching up to 99.84% accuracy and 99.86% macro F1. Performance differences between architectures are most pronounced under distribution mismatch and considerably smaller in the augmented-data setting. Across datasets, lower class-level performance is observed primarily among adjacent early-stage categories, particularly Very Mild and Mild impairment. These findings highlight the importance of evaluating deep learning architectures across multiple data conditions rather than relying on single-dataset performance.

0.20

A Trustworthy Clinical Decision Support Framework for Brain Tumor MRI Classification: Integrating Attention-Guided Learning, Explainable AI, and Out-of-Distribution Validation

cs.CV cs.AIcs.LG ·2026-10-06 ·Arjun Kumar Gupta, Harminder Pal Monga
publishedbenchmark similarity 0.68
Abstract · Accepted for presentation at the IC3AI-2026 IEEE conference in Dec 2026. It has been accepted/selected but is not yet published. 6 pages, 4 …

Deep learning models for brain tumor diagnosis need to do more than achieve high classification accuracy. For practical use, they should also provide understandable predictions, recognize unsuitable inputs, and work within a usable clinical system. This paper presents a framework for classifying brain MRI into four categories: glioma, meningioma, pituitary tumor, and no tumor. The model uses InceptionResNetV2 with a Convolutional Block Attention Module (CBAM), while Grad-CAM provides visual explanations of its predictions. A two-stage out-of-distribution (OOD) mechanism screens unsuitable inputs using an initial grayscale check followed by Mahalanobis distance, softmax confidence, and predictive entropy. These components are brought together in NeuroScan AI, a real-time web application. Evaluated on a Mendeley brain tumor MRI dataset of 12,064 images, the framework achieved 98.70% validation accuracy, 96.73% test accuracy, and a macro-average AUC of 0.9965. The OOD pipeline achieved 99% detection accuracy on a preliminary 100-image benchmark. Grad-CAM visualizations showed qualitative correspondence with clinically established tumor locations across all four classes. Overall, the work brings classification, explainability, input validation, and deployment into one framework, while recognizing that broader clinical and OOD validation is still required.

0.25

EigenGradCAM with AugSmooth: Enhancing Explainability and Precision in Multi-Stage Alzheimer's Disease Detection

cs.CV ·2026-10-23 ·Arsham Azam, Sagar Ashraf, Tayyaba Farhat, Rasikh Ali, Sheeraz Akram
similarity 0.67
Abstract

Alzheimer's disease (AD) is a progressive neurological disorder associated with memory loss, cognitive decline, and behavioral disturbances. Early and accurate diagnosis is essential, yet MRI-based deep learning models often lack interpretability, limiting their clinical use. This study presents an explainable deep learning approach for four-class AD staging using 2D axial MRI images. The method combines eigenvector-based Grad-CAM with gradient smoothing to improve saliency localization and heatmap stability. Principal component analysis is applied to gradient-weighted convolutional layers, while Gaussian noise is added to saliency weights before decomposition. To address class imbalance in the Moderate Dementia category, Wasserstein Generative Adversarial Network with Gradient Penalty (WGAN-GP) generates synthetic samples to balance the four-stage training distribution. Custom convolutional neural networks are trained on the Best Alzheimer MRI Dataset, achieving 97.2% test accuracy, 97.0% balanced accuracy, and a Matthews correlation coefficient of 0.944. The area under the ROC curve ranges from 0.96 to 0.99 across classes. Generated heatmaps highlight the hippocampus and entorhinal cortex, regions associated with Alzheimer's disease biomarkers. These findings suggest that the proposed approach combines strong classification performance with improved model interpretability, although further clinical validation is needed.

0.21

L0-Norm-Based CycleGAN for Unpaired Brain CT-to-MR Synthesis

cs.CV math.OC ·2026-10-23 ·Yunxiao Zhang, Shouqiang Du, Zexian Xu, Chuanlong Xu
similarity 0.67
Abstract · 13 pages, 2 figures

Computed tomography (CT) and magnetic resonance (MR) imaging provide complementary information for the brain, but acquiring both modalities is not always possible. The cycle-consistent adversarial network (CycleGAN) enables unpaired CT-to-MR synthesis, but because the standard L1-norm cycle?consistency penalty grows linearly with the residual magnitude, the network tends to focus on large residuals. This paper introduces an L0-norm-based cycle?consistency term, in which the L0-norm is approximated by a smooth and bounded function. This approximation not only increases sensitivity to small residuals but also effectively suppresses the influence of large residuals. The proposed model and an otherwise identical L1-norm baseline were trained on 102 images and evaluated on 9 test images. The proposed model achieves a lower mean squared error (0.02746 versus 0.03464, a 20.7% reduction), a higher mean peak signal-to-noise ratio (15.80 versus 14.77 dB), and a higher mean structural similarity index (0.5689 versus 0.5407). It also has a lower maximum MSE and higher minimum PSNR and SSIM than the baseline. These results indicate that modifying the cycle-consistency penalty can improve reconstruction accuracy on this dataset.

0.23

Explainable and CPU-Efficient Brain Tumor Classification from MRI Using Two-Phase EfficientNetB3 Fine-Tuning

cs.CV ·2026-11-18 ·Deepro Das, Saad Kabir Uddin, Mohammad Alauddin, Bornali Sarker, Thasnim Akhter
similarity 0.67
Abstract · 6 pages, 5 figures, 6 tables

Brain tumors are among the most lethal neurological disorders, with over 308,000 new diagnoses annually worldwide. Accurate classification of tumor type from Magnetic Resonance Imaging (MRI) scans is critical for treatment planning; however, manual radiological interpretation is time-consuming and prone to inter-observer variability. This paper proposes an automated deep learning pipeline for four-class brain MRI classification (glioma, meningioma, no tumor, and pituitary tumor) using EfficientNetB3 transfer learning with a custom classification head. A two-phase training strategy is adopted: Phase 1 trains the head with a frozen backbone (best validation accuracy: 92.77%), and Phase 2 selectively fine-tunes the top 37 layers at a 100x reduced learning rate (best validation accuracy: 94.91%). On an independent balanced test set of 1,600 MRI images, the system achieves 90.62% overall accuracy and a macro-average AUC of 0.9854. Gradient-weighted Class Activation Mapping (Grad-CAM) is integrated for class-discriminative visual explainability. The proposed system simultaneously addresses three dimensions absent in prior work: high accuracy, CPU-only computational efficiency, and clinical interpretability.

0.17